← Open Payments lookup

TAYLOR KING: Open Payments

NPI 1972258226 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,912 in 126 payments from 18 companies in 2025. Trend: 2023 $362 · 2024 $2,129 · 2025 $2,912

Food & beverage: $2,912
CompanyPaymentsAmount
ABBVIE INC.26$553
Janssen Biotech, Inc.17$492
Takeda Pharmaceuticals U.S.A., Inc.26$487
Madrigal Pharmaceuticals12$277
GENZYME CORPORATION12$211
Regeneron Pharmaceuticals, Inc.1$124
Lilly USA, LLC5$119
Phathom Pharmaceuticals, Inc.7$117
Boston Scientific Corporation1$117
Ardelyx, Inc.6$114

Products named: TREMFYA, DUPIXENT, ENTYVIO, REZDIFFRA, RINVOQ, OMVOH, LINZESS, VOQUEZNA.

Industry payments across IN — which companies pay providers there.